BridgeBio Pharma
BBIO
#1405
Rank
S$19.10 B
Marketcap
S$98.08
Share price
-2.75%
Change (1 day)
10.26%
Change (1 year)

BridgeBio Pharma (BBIO) - Total liabilities

Total liabilities on the balance sheet as of September 2026 : S$4.92 Billion

According to BridgeBio Pharma 's latest financial reports the company's total liabilities are S$4.92 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

BridgeBio Pharma - Total liabilities on balance sheet (from 2018 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31S$3.86 B19.71%
2024-12-31S$3.23 B29.51%
2023-12-31S$2.49 B-0.38%
2022-12-31S$2.50 B-1.39%
2021-12-31S$2.53 B222.23%
2020-12-31S$0.78 B275.43%
2019-12-31S$0.20 B75.45%
2018-12-31S$0.11 B-41.43%
2017-12-31S$0.20 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
OPKO Health
OPK
S$0.83 B-83.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
S$15.68 M-99.68%๐Ÿ‡บ๐Ÿ‡ธ USA